Tau acts as a mediator for Alzheimer's disease-related synaptic deficits

Area of Science:

• Neuroscience
• Cellular Biology
• Pathology

Background:

• Alzheimer's disease (AD) is characterized by amyloid plaques and neurofibrillary tangles.
• Early cellular changes and synaptic dysfunction precede clinical AD diagnosis.
• The interplay between amyloid-beta (Aβ) and tau pathologies in synaptic deficits is not fully understood.

Purpose of the Study:

• To elucidate the mechanistic interactions between Aβ and tau in initiating intracellular cascades leading to synaptic dysfunction.
• To update the amyloid cascade model by incorporating novel signaling pathways.
• To highlight the roles of calcium and tau as central mediators in Aβ-induced neurotoxicity and synaptic deficits.

Main Methods:

• Review and synthesis of recent research on Aβ and tau pathways.
• Discussion of Aβ-PrP(C)-Fyn-mediated neurotoxicity.
• Exploration of signaling molecules modulating tau mislocalization and hyperphosphorylation.

Main Results:

• Recent findings implicate Aβ-PrP(C)-Fyn signaling in neurotoxicity and synaptic deficits.
• Novel upstream and downstream signaling molecules influencing tau pathology have been identified.
• The interaction between Aβ and tau-initiated cascades remains a critical area of investigation.

Conclusions:

• An updated amyloid cascade model is proposed, emphasizing the central roles of calcium and tau.
• Understanding the interplay between Aβ and tau is crucial for deciphering early AD pathogenesis.
• Further research into these interactions may reveal new therapeutic targets for AD.